why choose us

First received: August 05, 2024

Clinical Trial: A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Investigation of Tolerability, Safety, and Pharmacokinetic Properties of a Single Oral Dose of Monlunabant in Male Japanese and Caucasian Participants With Normal Body Weight

Brief Summary: The study is testing a new study drug in healthy normal weight Japanese and Caucasian participants after a single dose.The aim of this study is to see if the new medicine is safe and how it works in the participants body.Oral monlunabant is a new medicine which cannot be prescribed by doctors but has previously been tested in humans.The participant will either get monlunabant or placebo or a combination of both.Which treatment the participant get is decided by chance.The study will last for about 49 days in total.

Read more